
    
      Three groups of subjects (MDD with partial remission and residual insomnia, primary insomnia,
      and healthy) will participate in the study. All subjects will complete a telephone screening,
      and if appropriate a complete face-to-face evaluation, to determine their eligibility for the
      study. All subjects meeting eligibility criteria for the study will complete a baseline MRS
      session to evaluate differences in GABA concentrations between the three groups.
    
  